Americas Agenda Healthcare for All Inc
Public records raise at least one point you should look into before giving.
What it says it does
TO ORGANIZE, EDUCATE, AND BUILD CONSENSUS AMONG A WIDE RANGE OF LABOR, BUSINESS, HEALTH CARE, CITIZEN GROUPS, AND OTHER DIVERSE INTERESTS IN SUPPORT OF ADOPTION OF HEALTH CARE POLICIES THAT WILL ASSURE AFFORDABLE ACCESS TO HIGH QUALITY HEALTH CARE FOR ALL AMERICANS.
- Income
- $16.1 million
- Spending
- $15.9 million
- Employees
- 3
- Volunteers
- 22
- Highest pay
- $400,871, executive director
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Financial health
We do not score finances when yearly spending is very small or the return has too little detail. The ratios stop meaning much at that size.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Governance
This return does not answer enough of the governance questions to score.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $15.6 million spent. DURING THE COURSE OF 2024, AMERICA'S AGENDA ("AAHCA") CONTINUED OUR ONGOING WORK TO BUILD AND STRENGTHEN BROAD CITIZEN COALITIONS THAT UNITE BUSINESSES, LABOR UNIONS, AND OTHER STAKEHOLDERS IN EFFECTIVE ADVOCACY TO ACHIEVE REFORMS THAT WILL ASSURE THAT EVERY AMERICAN HAS AFFORDABLE ACCESS TO HIGH-QUALITY HEALTHCARE. AS THE COST OF PRESCRIPTION DRUGS HAS EMERGED AS THE FASTEST-GROWING COMPONENT OF OVERALL HEALTH COSTS, AAHA HAS ADOPTED REDUCTION OF PRESCRIPTION DRUG COSTS AS A HIGH PRIORITY CONCERN AND FOCUS OF AAHCA ACTIVITY. AAHCA-ORGANIZED ADVOCACY CAMPAIGNS HAVE RESULTED IN ENACTMENT OF AMERICA'S AGENDA-DESIGNED STRATEGIES TO REDUCE PRESCRIPTION DRUG COSTS AND CAPTURE SUBSTANTIAL SAVINGS FOR PATIENTS, TAXPAYERS, STATE GOVERNMENT, AND PUBLIC EMPLOYEES IN SEVERAL STATES ACROSS THE COUNTRY. EACH OF OUR AAHCA STATE CAMPAIGNS HAS BUILT ON THE SUCCESS OF OUR POLICY INITIATIVE IN NEW JERSEY, WHERE IMPLEMENTATION OF THE AMERICA'S AGENDA-DESIGNED PUBLIC POLICY STRATEGY FOR CREATING A DYNAMICALLY COMPETITIVE MARKETPLACE FOR PHARMACY BENEFIT MANAGERS CAPTURED $2.52 BILLION IN PRESCRIPTION DRUG SAVINGS OVER 5 YEARS FOR STATE TAXPAYERS AND THE NEW JERSEY STATE EMPLOYEES HEALTH PLAN. AAHCA'S FEDERAL MEDICARE REFORM ADVOCACY INITIATIVE AIMS TO ELIMINATE PERVERSE PRESCRIPTION BENEFIT MANAGER (PBM) INCENTIVES TO PROVIDE MEDICARE PARTICIPANTS HIGHER, RATHER THAN LOWER, PRICED DRUGS AND PREVENT PBM CONFLICTS OF INTEREST THAT DRIVE COSTS HIGHER FOR AMERICA'S SENIORS.THE FOLLOWING EXAMPLES HIGHLIGHT ACCOMPLISHMENTS OF CONTINUING AAHCA ADVOCACY INITIATIVES OVER THE COURSE OF 2024: - IN COLORADO, DURING 2024, AAHCA EXPANDED OUR ADVOCACY COALITION OF COLORADO CITIZEN ORGANIZATIONS THAT HAD BUILT THE MOMENTUM LEADING TO THE 2022 ENACTMENT OF COLORADO'S COMPETITIVE PHARMACY BENEFITS MANAGER MARKETPLACE ACT. THE EXPANDED COALITION UNITED AROUND CORE PRINCIPLES FOR A BROADER PUBLIC AND PRIVATE SECTOR PRESCRIPTION DRUG MARKET REFORM WITH THE GOAL OF SUBSTANTIALLY REDUCING COST OF PRESCRIPTION DRUGS FOR PATIENTS IN ALL OF COLORADO'S PUBLIC AND PRIVATE SECTOR INSURANCE PROGRAMS BY ELIMINATING THE PRICE-INCREASING PRESCRIPTION DRUG MANAGER ("PBM") PRACTICE OF PRESCRIPTION DRUG ARBITRAGE AND BY CREATING A NEW, COMPETITIVE MARKETPLACE FOR PBM SERVICES WITH TRANSPARENT, COMPETITIVE DOLLAR-VALUE PRICING. COLORADO AAHCA COALITION ORGANIZATIONS ADVOCATED FOR THE URGENCY OF PRIORITIZING ENACTMENT OF EFFECTIVE PRESCRIPTION DRUG AFFORDABILITY REFORMS IN THE NEXT LEGISLATIVE SESSION, COMMENCING IN 2025, AND AS A RESULT OF THESE EFFORTS OVER THE COURSE OF 2024, A BIPARTISAN GROUP OF LEGISLATIVE LEADERS STEPPED FORWARD AS ADVOCATES AND PROSPECTIVE SPONSORS IN THE COLORADO LEGISLATURE.- IN MINNESOTA, AAHCA REMOBILIZED OUR ADVOCACY CAMPAIGN PARTNER ORGANIZATIONS WHO HAD WON ENACTMENT OF MINNESOTA'S 2021 PBM REVERSE AUCTION STATUTE FOR THE PURPOSE OF DEFENDING AGAINST A 2024 PBM INDUSTRY-BACKED INITIATIVE TO REXCIND THE REFORMS AFTER THEY HAD REDIRECTED TENS OF MILLIONS OF DOLLARS PER YEAR OF PBM GROSS REVENUES BACK TO SAVINGS FOR MINNESOTA TAX-PAYERS AND PUBLIC EMPLOYEE FAMILIES. DURING THE EXTENDED SESSION OF THE 2024 SESSION OF THE MINNESOTA LEGISLATURE, THE ADVOCACY AND EDUCATIONAL WORK OF AAHCA AND OUR CAMPAIGN COALITION PARTNERS ULTIMATELY SUCCEEDED IN THWARTING THE ATTEMPT TO RESCIND THR MINNESOTA'S PBM REVERSE AUCTION REFORM. - IN IOWA, AAHC, IN COORDINATION WITH OUR STATE COALITION PARTNERS, PROVIDED TECHNICAL SUPPORT AND ADVISEMENT TO OFFICERS OF THE STATE ADMINISTRATION - ALIGNED IN GOALS WITH STATE LEGISLATORS TO WHOM AAHCA HAS PROVIDED ADVISEMENT EARLIER IN 2024 - WITH A COMMON OBJECTIVE OF IMPLEMENTING A COMPETITIVE, TECHNOLOGY-ENABLED PBM REVERSE AUTION PROCESS MODELED ON AAHCA PRINCIPLES THAT HAVE CAPTURED BILLIONS OF TAXPAYER DOLLARS IN PRESCRIPTION DRUG SAVINGS FOR STATE GOVERNMENTS AND PUBLIC EMPLOYEE FAMILIES IN NEW JERSEY, COLORADO, AND MINNESOTA. - THE AAHCA COALITION FOR MEDICARE PART D PRESCRIPTION DRUG MARKET REFORMS HAS AIMED ITS FOCUS OVER THE COURSE OF 2023 AND 2024 ON REDUCING PRESCRIPTION DRUG COSTS FOR AMERICA'S SENIORS BY PROHIBITING LINKAGE OF PHARMACY BENEFIT MANAGER INCOME TO THE LIST PRICE OF PRESCRIPTION DRUGS. EXTENSIVE AAHCA ADVOCACY AND PUBLIC EDUATION OVER THE COURSE OF 2024, INCLUDING AN EXTENSIVE ONLINE PUBLIC EDUATION CAMPAIGN, CONTRIBUTED TO THE DECEMBER 2024 AGREEMENT ON A COMMON SET OF PRESCRIPTION DRUG AFFORDABILITY REFORMS BY BIPARTISAN LEADERSHIP IN BOTH THE US SENATE AND THE HOUSE OF REPRESENTATIVES. THE DECEMBER 2024 AGREEMENT WAS GROUNDED IN A SET OF BILLS ADVOCATED FOR BY AAHCA AND ADOPTED UNANIMOUSLY BY THE US SENATE FINANCE COMMITTEE, AND THE ENERGY AND COMMERCE COMMITTEE AND THE WAYS AND MEANS COMMITTEE OF THE US HOUSE OF REPRESETNATIVES. ATHOUGH THE BROADLY SUPPORTED DECEMBER 2024 PRESCRIPTION DRUG MARKET REFORMS WERE NOT ULTIMATELY VOTED UPON BEFORE CONGRESS ADJOURNED FOR ITS CHRISTMAS RECESS, THEY ARE EXPECTED PROVIDE THE FRAMEWORK FOR CONGRESSIONAL CONSIDERATION OF PRESCRIPTION DRUG AFFORDABILITY REFORM IN THE 119TH CONGRESS.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(4) social welfare organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Caution.
The IRS master file records contributions to this 501(c)(4) social welfare organization as not deductible.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since November 2006.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.